How effective is Ambien for Primary Insomnia ?

Summary

Overall ratings: 3.5/5
Long term ratings: 3.5/5

This is a reivew of how effective Ambien (zolpidem tartrate) is for Primary insomnia and for what kind of people. The study is created by eHealthMe from 135 Ambien users and is updated continuously.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on zolpidem tartrate (the active ingredients of Ambien) and Ambien (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. (latest outcomes from Ambien 75,817 users)

What is Primary insomnia?

Primary insomnia (sleep disorder) has been reported by people with primary insomnia, generalized anxiety disorder, high blood pressure, attention deficit hyperactivity disorder, high blood cholesterol (latest reports from 803 Primary insomnia patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Feb, 25, 2019

135 people are studied for taking Ambien in Primary insomnia


Overall effectiveness (number of people)

Does Ambien work for your Primary insomnia (overall)?

Long term effectiveness (number of people)

Does Ambien work for your Primary insomnia (long term)?

Ambien effectiveness for Primary insomnia (number of people)

Overall:
  • not at all: 0
  • somewhat: 23
  • moderate: 45
  • high: 49
  • very high: 18
Long Term:
  • not at all: 0
  • somewhat: 17
  • moderate: 34
  • high: 34
  • very high: 15

Gender of people who take Ambien for Primary insomnia *

  • female: 77.78 %
  • male: 22.22 %

Age of people who take Ambien for Primary insomnia *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.48 %
  • 20-29: 8.89 %
  • 30-39: 20.74 %
  • 40-49: 27.41 %
  • 50-59: 25.19 %
  • 60+: 16.3 %

Who finds Ambien more effective for Primary Insomnia?


Gender of people who take Ambien for Primary insomnia *

  • female: 77.61 %
  • male: 22.39 %

Age of people who take Ambien for Primary insomnia *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 2.99 %
  • 20-29: 10.45 %
  • 30-39: 14.93 %
  • 40-49: 19.4 %
  • 50-59: 31.34 %
  • 60+: 20.9 %

* Approximation only. Some reports may have incomplete information.


Do you take Ambien?

You are not alone:




Related studies:



Recent updates

Recent general studies
Recent personal studies


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.